Histogen Gets $5.35M

San Diego-based Histogen said Friday that it has raised $5.35M for its regenerative medicine products. According to the firm, the round came from Secure Medical Inc., CellCeuticals Skin Care Inc., and angel investor Leonard H. Laving of Alberto-Culver Company. The firm said it is developing solutions based on newborn fibroblasts; the firm's products are targeted at hair growth, wound, and hernia repair. The firm said the funding will go towards Phase 1 clinical trials and 510k submissions, as well as upscale its manufacturing operations.